Original language | English (US) |
---|---|
Pages (from-to) | 459-465 |
Number of pages | 7 |
Journal | Morbidity and Mortality Weekly Report |
Volume | 71 |
Issue number | 12 |
DOIs | |
State | Published - Mar 25 2022 |
ASJC Scopus subject areas
- Epidemiology
- Health(social science)
- Health, Toxicology and Mutagenesis
- Health Information Management
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Morbidity and Mortality Weekly Report, Vol. 71, No. 12, 25.03.2022, p. 459-465.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
AU - IVY Network
AU - Tenforde, Mark W.
AU - Self, Wesley H.
AU - Gaglani, Manjusha
AU - Ginde, Adit A.
AU - Douin, David J.
AU - Talbot, H. Keipp
AU - Casey, Jonathan D.
AU - Mohr, Nicholas M.
AU - Zepeski, Anne
AU - McNeal, Tresa
AU - Ghamande, Shekhar
AU - Gibbs, Kevin W.
AU - Files, D. Clark
AU - Hager, David N.
AU - Shehu, Arber
AU - Prekker, Matthew E.
AU - Frosch, Anne E.
AU - Gong, Michelle N.
AU - Mohamed, Amira
AU - Johnson, Nicholas J.
AU - Srinivasan, Vasisht
AU - Steingrub, Jay S.
AU - Peltan, Ithan D.
AU - Brown, Samuel M.
AU - Martin, Emily T.
AU - Monto, Arnold S.
AU - Khan, Akram
AU - Hough, Catherine L.
AU - Busse, Laurence W.
AU - Duggal, Abhijit
AU - Wilson, Jennifer G.
AU - Qadir, Nida
AU - Chang, Steven Y.
AU - Mallow, Christopher
AU - Rivas, Carolina
AU - Babcock, Hilary M.
AU - Kwon, Jennie H.
AU - Exline, Matthew C.
AU - Botros, Mena
AU - Lauring, Adam S.
AU - Shapiro, Nathan I.
AU - Halasa, Natasha
AU - Chappell, James D.
AU - Grijalva, Carlos G.
AU - Rice, Todd W.
AU - Jones, Ian D.
AU - Stubblefield, William B.
AU - Baughman, Adrienne
AU - Womack, Kelsey N.
AU - Rhoads, Jillian P.
N1 - Funding Information: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Samuel M. Brown reports personal fees from Hamilton ventilators, and grants from the National Institutes of Health (NIH) and the U.S. Department of Defense (DoD). Jonathan D. Casey reports grants from the NIH and DoD. Steven Y. Chang was a speaker for La Jolla Pharmaceuticals in 2018, consulted for PureTech Health in 2020, and consulted for Kiniska Pharmaceuticals in December 2021. David J. Douin reports a grant from NIH/National Institute of General Medical Sciences. Abhijit Duggal reports grants from NIH and participation on a Steering Committee for ALungTechnologies. Matthew C. Exline reports support from Abbott Labs for sponsored talks. D. Clark Files reports personal consultant fees from Cytovale and membership on a data and safety monitoring board (DSMB) from Medpace. Anne E. Frosch reports grants from NIH/National Institute of Allergy and Infectious Diseases (NIAID), NIH/National Heart, Lung, and Blood Institute (NHLBI), and NIH/INSIGHT/ICC. Manjusha Gaglani reports grants from Abt Associates, Westat, and Janssen. Adit A. Ginde reports grants from NIH, DoD, AbbVie, and Faron Pharmaceuticals. Michelle N. Gong reports grants from NIH and the Agency for Healthcare Research and Quality (AHRQ), and DSMB membership fees from Regeneron, outside the submitted work. Carlos G. Grijalva reports consultancy fees from Pfizer, Merck, and Sanofi-Pasteur; grants from Campbell Alliance/Syneos Health, NIH, the Food and Drug Administration, AHRQ, and Sanofi. David N. Hager reports grants from NIH/NHLBI. Natasha Halasa reports grants and nonfinancial support from Sanofi, and grants from Quidel and NIH. Nicholas J. Johnson reports grants from NIH, DoD, and Medic One Foundation. Akram Khan reports grants from United Therapeutics, Johnson & Johnson, and Eli Lilly. Jennie H. Kwon reports grants from NIH/NIAID. Adam S. Lauring reports personal fees from Sanofi and Roche, and grants from NIH and Burroughs Wellcome Fund. Christopher J. Lindsell reports grants from NIH, DoD, and the Marcus Foundation; contract fees from bioMerieux, Endpoint Health, Entegrion Inc, and AbbVie; and a patent for risk stratification in sepsis and septic shock. Emily T. Martin reports grants from Merck. Arnold S. Monto reports a grant from NIH. Ithan D. Peltan reports grants from NIH, Janssen Pharmaceuticals, and Intermountain Research and Medical Foundation, and institutional support from Asahi Kasei Pharma and Regeneron. Todd W. Rice reports grants from NIH, DoD, and AbbVie and personal fees from Cumberland Pharmaceuticals, Inc., and Cytovale, Inc. No other potential conflicts of interest were disclosed.
PY - 2022/3/25
Y1 - 2022/3/25
UR - http://www.scopus.com/inward/record.url?scp=85127043344&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127043344&partnerID=8YFLogxK
U2 - 10.15585/MMWR.MM7112E1
DO - 10.15585/MMWR.MM7112E1
M3 - Article
C2 - 35324878
AN - SCOPUS:85127043344
SN - 0149-2195
VL - 71
SP - 459
EP - 465
JO - Morbidity and Mortality Weekly Report
JF - Morbidity and Mortality Weekly Report
IS - 12
ER -